Single-Arm Phases 1 and 2 Trial of Niraparib in Combination with Pembrolizumab in Patients with Recurrent Platinum-Resistant Ovarian Carcinoma

Panagiotis A. Konstantinopoulos, Steven Waggoner, Gregory A. Vidal, Monica Mita, John W. Moroney, Robert Holloway, Linda Van Le, Jasgit C. Sachdev, Eloise Chapman-Davis, Gerardo Colon-Otero, Richard T. Penson, Ursula A. Matulonis, Young Bae Kim, Kathleen N. Moore, Elizabeth M. Swisher, Anniina Färkkilä, Alan D'Andrea, Erica Stringer-Reasor, Jing Wang, Nathan BuerstatteSujata Arora, Julie R. Graham, Dmitri Bobilev, Bruce J. Dezube, Pamela Munster

Research output: Contribution to journal › Article › peer-review

100 Scopus citations

Fingerprint

Dive into the research topics of 'Single-Arm Phases 1 and 2 Trial of Niraparib in Combination with Pembrolizumab in Patients with Recurrent Platinum-Resistant Ovarian Carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences